GlassScriptPhysician profile
Laura L Velez
NPI 1215076781
$5,049.47
in general payments reported to CMS, 2019-2025
26 companies · $1,212 in 2025
The $1,212 reported for 2025 was more than what 87% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $845 · 2022: $1,008 · 2023: $954 · 2024: $1,030 · 2025: $1,212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,196.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $704.35 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $559.85 | 2021-2025 | Farxiga, Wainua, Andexxa |
| Novo Nordisk INC | $400.27 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Actelion Pharmaceuticals US, INC. | $382.84 | 2021-2023 | Opsumit |
| Novartis Pharmaceuticals Corporation | $376.23 | 2023-2025 | |
| Amgen INC. | $374.51 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $365.61 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Abbott Laboratories | $363.99 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $285.59 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.63 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $202.14 | 2021-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $199.05 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.02 | 2021-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $148.21 | 2021-2023 | |
| Amarin Pharma, INC. | $51.66 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $43.86 | 2024 | Arcalyst |
| Baxter Healthcare | $35.87 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $23.33 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $22.78 | 2025 | General - Tachy |
| Impulse Dynamics (USA) INC. | $20.81 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $19.54 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.52 | 2023 | Onpattro |
| Lilly USA, LLC | $17.24 | 2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $14.71 | 2025 | Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $13.82 | 2022 | |
| Irhythm Technologies, INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Velez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.